Less Ads, More Data, More Tools Register for FREE

Pin to quick picksADAM.L Regulatory News (ADAM)

  • There is currently no data for ADAM

Director/PDMR Shareholding

28 Nov 2016 10:00

RNS Number : 3007Q
Adamas Finance Asia Limited
28 November 2016
 

ADAMAS FINANCE ASIA LIMITED

(ADAM or the "Company")

Director/PDMR Shareholding

 

 

The Company was notified on 28 November 2016 that Barry Lau, Managing Partner of the Company's investment manager, Adamas Asset Management (HK) Limited, had acquired 25,000 ordinary shares of no par value each in ADAM on the dates detailed below:

 

Date

Purchase price (US$)

No. of shares acquired

 

 

 

24 November 2016

0.560

10,000

25 November 2016

0.560

15,000

 

Following these transactions, Mr Lau is interested in 420,000 ordinary shares, representing 0.22% of the Company's issued share capital.

 

The attached notifications, made in accordance with the requirements of the EU Market Abuse Regulation, give further detail.

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

 Barry Lau

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Managing Partner of the Company's investment manager, Adamas Asset Management (HK) Limited

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Adamas Finance Asia Limited

b)

 

LEI

 

 

-

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary shares of no par value in Adamas Finance Asia Limited

 

VGG008271162

 

 

b)

 

Nature of the transaction

 

 

Acquisition of shares

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

0.560

0.560

10,000

15,000

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

 

 

 

25,000

 

 

US$14,000

 

e)

 

Date(s) of the transaction

 

 

24 and 25 November 2016

f)

 

Place of the transaction

 

 

London Stock Exchange, AIM

Enquiries:

Adamas Finance Asia Limited

 

John Croft, Non-Executive Chairman

+44 (0) 1825 830 587

 

 

Nominated Adviser:

 

WH Ireland Limited

+44 (0) 113 394 6600

Tim Feather

 

Ed Allsopp

 

 

 

Broker:

 

finnCap Limited

+44 (0) 20 7220 0500

William Marle

 

Grant Bergman

 

 

 

 

 

Public Relations Advisers:

 

First City Public Relations (Hong Kong)

+852 2854 2666

Allan Piper

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHKVLBLQFFEFBQ
Date   Source Headline
24th Oct 201810:24 amRNSNet Asset Value Update
16th Oct 201810:34 amRNSDirector/PDMR Shareholding
13th Sep 20187:00 amRNSInterim Results for Six Months Ended 30 June 2018
17th Aug 201811:43 amRNSResult of AGM
13th Aug 201810:50 amRNSNet Asset Value Update
26th Jul 201812:06 pmRNSNet Asset Value Update
23rd Jul 20189:44 amRNSDisposal of Interest in Global Pharm
11th Jul 201810:38 amRNSResult of General Meeting
28th Jun 20183:50 pmRNSPosting of Annual Report and Accounts
21st Jun 20187:00 amRNSFinal Results for the Year Ended 31 December 2017
21st Jun 20187:00 amRNSAppointment of Broker
15th Jun 20188:36 amRNSDisposal of Interest in Global Pharm & GM Notice
27th Apr 20187:00 amRNSUpdate on Disposal of Interest in Global Pharm
26th Apr 20181:57 pmRNSResult of General Meeting
20th Apr 20188:49 amRNSDirector/PDMR Shareholding
5th Apr 20183:54 pmRNSDisposal and Notice of General Meeting
29th Mar 20187:00 amRNSUpdate on Disposal of Interest in Global Pharm
26th Mar 20184:44 pmRNSIncreased Ownership in HKMH
19th Mar 20187:00 amRNSNew Investment
8th Feb 201812:17 pmRNSUpdate - Net Asset Value
2nd Feb 20188:24 amRNSDirector/PDMR Shareholding
15th Jan 20187:00 amRNSFurther re. Disposal of Interest in Global Pharm
21st Dec 20178:54 amRNSIncrease in Shareholding in Hong Kong Mining
31st Oct 201710:23 amRNSNet Asset Value Update
2nd Oct 20177:00 amRNSAppointment of Director
22nd Sep 20177:00 amRNSInterim Results For Six Months End 30 June 2017
20th Sep 201711:18 amRNSAGM and Share Consolidation
15th Sep 20177:00 amRNSDisposal of Interest in Global Pharm
30th Aug 20174:50 pmRNSProposed Share Consolidation
4th Aug 20173:36 pmRNSUpdate on Global Pharm Convertible Bond
27th Jul 20177:00 amRNSNet Asset Value(s)
20th Jul 20179:43 amRNSDirectorate Change
20th Jul 20179:27 amRNSAnnual General Meeting
3rd Jul 20179:14 amRNSAppointment of Director
29th Jun 201710:45 amRNSFinal Results
22nd Jun 20178:46 amRNSFurther Payment of Proceeds for TTS Disposal
15th Jun 20179:43 amRNSPayment of Proceeds for TTS Project Disposal
25th May 201711:06 amRNSResult of Meeting
2nd May 20177:00 amRNSChange of Investment Manager and Investing Policy
24th Feb 201711:45 amRNSUPDATE ON TTS PROJECT DISPOSAL
8th Feb 20179:26 amRNSUPDATE ON TTS PROJECT DISPOSAL
31st Jan 20177:00 amRNSDistribution from GCCF
23rd Jan 20179:15 amRNSUPDATE: REDEMPTION OF GLOBAL PHARM CONVERTIBLE
13th Jan 20178:15 amRNSUPDATE ON TTS PROJECT DISPOSAL
4th Jan 20179:00 amRNSProposed Disposal
29th Dec 20167:00 amRNSDirector/PDMR Shareholding
22nd Dec 20161:18 pmRNSDirector/PDMR Shareholding
20th Dec 20164:19 pmRNSDirector/PDMR Shareholding
13th Dec 20169:23 amRNSDirector/PDMR Shareholding
6th Dec 201612:34 pmRNSCorrection to Director/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.